Merck sues the US government to stop negotiating the price of Medicare drugs

NEW YORK, June 6 (Reuters) – Merck & Co (MRK.N) sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), which he says violates the Fifth and First Amendments to the United States Constitution. This is the first attempt by a drugmaker to defy the law, which the pharmaceutical industry says will result in lost profits forcing them to pull out of developing innovative new treatments. Americans pay more for prescription medicines than any other country. The Biden…

Read More